RPX Seminars 2012

We are pleased to present our 2012 seminars in Seattle, Boston and New York discussing current issues affecting the patent landscape.  We offer our ongoing review of the latest patent acquisition and litigation trends, with views into transaction volume, pricing, and other marketplace activities.  In addition, leveraging RPX’s proprietary databases, we investigate how to answer the questions from your CFO about patent risk exposure, risks of being sued, costs involved, and whether your company is a target. We will walk through our proprietary methodology for predicting case frequency, severity, and costs. We will conclude with a review of a real company’s patent risk, and leave you with a framework for answering such questions for your company.

Seminar Agenda

Seattle: Thursday, February 2, 2012
Boston: Tuesday, February 7, 2012
New York: Thursday, February 9, 2012

2:00P             Registration

2:45P             Welcome

3:00P             Patent Acquisition and Litigation Update

This session offers a review of key updates on recent patent litigation filings and acquisition activities in the patent marketplace with views into transaction volume, pricing, and other emerging trends.  In particular, we will examine three key acquisition trends that have developed in recent months:

–        NPE litigation growth and number of multi-defendant cases
–        Impact of new NPE entrants on litigations
–        Effect of the Nortel transaction on the patent market

Speaker: Kevin Barhydt, Vice President and Head of Acquisitions and Analysis, RPX Corporation

3:45P             Break 

4:00P             How to Quantify Patent Risk in Terms Your CFO Can Understand

When the CFO asks about your company’s exposure to patent risk, it can be challenging to provide answers to questions such as:  What are our chances of being sued?  How much will it cost?  What factors impact whether we will be targeted?  What patents are most likely to be litigated?  How do we assess the risks of an acquisition?  Leveraging RPX’s proprietary databases, we provide a structured framework for answering these questions using our unique methodology for predicting case frequency, severity and costs as well as walk through an actual company risk dossier.  This methodology serves as the basis for an actuarially certified underwriting model that has been approved by insurance regulators.

Speaker: David Anderson, Senior Director, Corporate Development, RPX Corporation

5:15P             Conference Adjourns